sorafenib has been researched along with caryophyllene oxide in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (caryophyllene oxide) | Trials (caryophyllene oxide) | Recent Studies (post-2010) (caryophyllene oxide) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 115 | 0 | 96 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abete, L; Briz, O; Di Giacomo, S; Di Sotto, A; Lozano, E; Marin, JJG; Mazzanti, G; Monte, MJ; Sanchez-Vicente, L | 1 |
1 other study(ies) available for sorafenib and caryophyllene oxide
| Article | Year |
|---|---|
Chemosensitization of hepatocellular carcinoma cells to sorafenib by β-caryophyllene oxide-induced inhibition of ABC export pumps.
Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Polycyclic Sesquiterpenes; Sorafenib | 2019 |